|
20 Sep 2023 |
Orionis Biosciences Announces Collaboration with Genentech to Discover and Develop Molecular Glue Class Medicines
|
|
20 Sep 2023 |
Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
|
|
19 Sep 2023 |
Pharmanovia acquires global central nervous system (CNS) portfolio from Sanofi
|
|
12 Sep 2023 |
Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer
|
|
12 Sep 2023 |
Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform
|
|
11 Sep 2023 |
Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium
|
|
09 Sep 2023 |
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
|
|
05 Sep 2023 |
XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
|
|
01 Sep 2023 |
Otsuka Pharmaceutical to Acquire Mindset Pharma
|
|
01 Sep 2023 |
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases.
|
|
31 Aug 2023 |
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
|
|
29 Aug 2023 |
Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers
|
|
29 Aug 2023 |
Deargen and Serengen Partner to Accelerate Drug Discovery
|
|
23 Aug 2023 |
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
|
|
22 Aug 2023 |
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
|
|
16 Aug 2023 |
Chiesi Global Rare Diseases Announces Co-Development Agreement with Aliada Therapeutics to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
|
|
16 Aug 2023 |
Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
|
|
15 Aug 2023 |
Harmony Biosciences To Acquire Zynerba Pharmaceuticals, Inc.
|
|
12 Aug 2023 |
HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK Cells
|
|
11 Aug 2023 |
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
|
|
11 Aug 2023 |
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
|
|
28 Jul 2023 |
Biogen to Acquire Reata Pharmaceuticals
|
|
27 Jul 2023 |
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
|
|
26 Jul 2023 |
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
|
|
26 Jul 2023 |
Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
|
